NR1H3 and thyroid gland carcinoma: Moreover, the expression of NR1H3 was also significantly lower in other types of cancers compared with the corresponding normal tissues, such as colon adenocarcinoma (COAD), kidney chromophobe (KICH), lung adenocarcinoma (LUAD) and thyroid carcinoma (THCA) tissues (Figure 1A).